- Home
- UGI vs RGC Comparison
UGI vs RGC Comparison
Compare UGI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UGI | RGC |
|---|---|---|
| Founded | 1940 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 13.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | UGI | RGC |
|---|---|---|
| Price | $37.06 | $23.78 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $44.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 118.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.88 | N/A |
| Revenue Next Year | $2.27 | N/A |
| P/E Ratio | $14.04 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.03 | $3.99 |
| 52 Week High | $41.34 | $950.00 |
Technical Indicators
Market Signals| Indicator | UGI | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 40.14 | 41.43 |
| Support Level | $36.86 | $11.83 |
| Resistance Level | $37.43 | $26.42 |
| Average True Range (ATR) | 0.72 | 2.62 |
| MACD | -0.13 | -0.61 |
| Stochastic Oscillator | 31.33 | 11.51 |
Price Performance
Historical ComparisonAbout UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.